Peptidomimetic macrocycles and uses thereof
US10253067B2 · kind B2 · utility
1Cited by
307References
84Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 18, 2016 |
| Grant date | Apr 9, 2019 |
| Priority date | — |
| Expiry date | Aug 1, 2036 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/4748
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for treating liquid cancer, determined to lack a p53 deactivation mutation, in a subject are provided. Also provided are peptidomimetic macrocycles for use in treatment of a liquid cancer, determined to lack a p53 deactivation mutation, in a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.